The market size of Retinitis Pigmentosa in the 7MM was USD 237.27 million (in 2017). Among the 7MM countries, the United States had the highest market size of 56.40% of the total market in 2017.
According to DelveInsight, the total diagnosed prevalent population of Retinitis Pigmentosa (RP) in the 7MM was 253,420 in 2017. These cases are expected to increase with a significant CAGR during the study period (2017–2030).
Increasing R&D Activities, Raising Awareness and Novel Curative Therapies are some of the key drivers of the Retinitis Pigmentosa markets.
The key player in the Retinitis Pigmentosa market includes Horama, jCyte, Allergan, Dompé Farmaceutici, Neurotech Pharmaceuticals, ReNeuron Limited and others.
For more detailed information visit:
https://www.delveinsight.com/report-store/retinitis-pigmentosa-marke